{"acquisitions":[],"changes":[{"companyHref":"/c/electra-therapeutics-com","date":"2026-09-28","documentUrl":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml","domain":"electra-therapeutics.com","fact":"latest round","name":"Electra Therapeutics, Inc","new":{"amountUsd":134188389,"date":"2025-10-15","lead":null,"type":null},"old":{"amountUsd":134200000,"date":"2025-10-15","lead":null,"type":null},"publisher":"SEC EDGAR","reason":null,"retrievedAt":"2026-09-25","slug":"electra-therapeutics-com","status":"sourced","url":"https://whoraisedwhat.com/c/electra-therapeutics-com"},{"companyHref":"/c/electra-therapeutics-com","date":"2026-09-25","documentUrl":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml","domain":"electra-therapeutics.com","fact":"latest round","name":"Electra Therapeutics, Inc","new":{"amountUsd":134200000,"date":"2025-10-15","lead":null,"type":null},"old":{"amountUsd":134200000,"date":"2025-10-15","lead":null,"type":"seed"},"publisher":"SEC EDGAR","reason":null,"retrievedAt":"2026-09-25","slug":"electra-therapeutics-com","status":"sourced","url":"https://whoraisedwhat.com/c/electra-therapeutics-com"},{"companyHref":"/c/electra-therapeutics-com","date":"2026-09-25","documentUrl":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml","domain":"electra-therapeutics.com","fact":"provenance:round","name":"Electra Therapeutics, Inc","new":{"publisher":"SEC EDGAR","status":"sourced","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"},"old":{"publisher":"sec-edgar","status":"attributed","url":null},"publisher":"SEC EDGAR","reason":null,"retrievedAt":"2026-09-25","slug":"electra-therapeutics-com","status":"sourced","url":"https://whoraisedwhat.com/c/electra-therapeutics-com"}],"country":"US","description":"Electra Therapeutics develops antibody therapies that target Signal Regulatory Proteins to treat immunological diseases and cancer. It serves patients with inflammatory conditions such as sHLH that lack treatment options, led by ELA026. Its SIRP-targeting approach depletes pathological immune cells while sparing healthy ones.","domain":"electra-therapeutics.com","employees":null,"founded":2018,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":37.65354,"lng":-122.416866,"location":"South San Francisco, CA","multiples":[],"name":"Electra Therapeutics, Inc","people":[{"name":"Beth Seidenberg, M.D.","role":"director","slug":"beth-seidenberg-m-d"},{"name":"Carl Gordon, Ph.D.","role":"director","slug":"carl-gordon-ph-d"},{"name":"Matthew Fust","role":"director","slug":"matthew-fust"},{"name":"Nancy Stagliano, Ph.D.","role":"director","slug":"nancy-stagliano-ph-d"},{"name":"Quehuong (Kathy) Dong, Pharm.D.","role":"director","slug":"quehuong-kathy-dong-pharm-d"},{"name":"Quehuong (Kathy) Dong, Pharm.D.","role":"executive","slug":"quehuong-kathy-dong-pharm-d"},{"name":"Thomas Geninatti, Ph.D.","role":"director","slug":"thomas-geninatti-ph-d"}],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":134188389,"connectionsAmong":[{"a":"p/beth-seidenberg-m-d","b":"p/carl-gordon-ph-d","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":null,"type":"board","via":"c/electra-therapeutics-com"},{"a":"p/beth-seidenberg-m-d","b":"p/carl-gordon-ph-d","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":"2025-10-29","type":"worked_with","via":"c/electra-therapeutics-com"},{"a":"p/beth-seidenberg-m-d","b":"p/matthew-fust","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":null,"type":"board","via":"c/electra-therapeutics-com"},{"a":"p/beth-seidenberg-m-d","b":"p/matthew-fust","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":"2025-10-29","type":"worked_with","via":"c/electra-therapeutics-com"},{"a":"p/beth-seidenberg-m-d","b":"p/nancy-stagliano-ph-d","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":null,"type":"board","via":"c/electra-therapeutics-com"},{"a":"p/beth-seidenberg-m-d","b":"p/nancy-stagliano-ph-d","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":"2025-10-29","type":"worked_with","via":"c/electra-therapeutics-com"},{"a":"p/beth-seidenberg-m-d","b":"p/quehuong-kathy-dong-pharm-d","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":null,"type":"board","via":"c/electra-therapeutics-com"},{"a":"p/beth-seidenberg-m-d","b":"p/quehuong-kathy-dong-pharm-d","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":"2025-10-29","type":"worked_with","via":"c/electra-therapeutics-com"},{"a":"p/beth-seidenberg-m-d","b":"p/thomas-geninatti-ph-d","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":null,"type":"board","via":"c/electra-therapeutics-com"},{"a":"p/beth-seidenberg-m-d","b":"p/thomas-geninatti-ph-d","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":"2025-10-29","type":"worked_with","via":"c/electra-therapeutics-com"},{"a":"p/carl-gordon-ph-d","b":"p/matthew-fust","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":null,"type":"board","via":"c/electra-therapeutics-com"},{"a":"p/carl-gordon-ph-d","b":"p/matthew-fust","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":"2025-10-29","type":"worked_with","via":"c/electra-therapeutics-com"},{"a":"p/carl-gordon-ph-d","b":"p/nancy-stagliano-ph-d","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":null,"type":"board","via":"c/electra-therapeutics-com"},{"a":"p/carl-gordon-ph-d","b":"p/nancy-stagliano-ph-d","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":"2025-10-29","type":"worked_with","via":"c/electra-therapeutics-com"},{"a":"p/carl-gordon-ph-d","b":"p/quehuong-kathy-dong-pharm-d","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":null,"type":"board","via":"c/electra-therapeutics-com"},{"a":"p/carl-gordon-ph-d","b":"p/quehuong-kathy-dong-pharm-d","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":"2025-10-29","type":"worked_with","via":"c/electra-therapeutics-com"},{"a":"p/carl-gordon-ph-d","b":"p/thomas-geninatti-ph-d","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":null,"type":"board","via":"c/electra-therapeutics-com"},{"a":"p/carl-gordon-ph-d","b":"p/thomas-geninatti-ph-d","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":"2025-10-29","type":"worked_with","via":"c/electra-therapeutics-com"},{"a":"p/matthew-fust","b":"p/nancy-stagliano-ph-d","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":null,"type":"board","via":"c/electra-therapeutics-com"},{"a":"p/matthew-fust","b":"p/nancy-stagliano-ph-d","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":"2025-10-29","type":"worked_with","via":"c/electra-therapeutics-com"},{"a":"p/matthew-fust","b":"p/quehuong-kathy-dong-pharm-d","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":null,"type":"board","via":"c/electra-therapeutics-com"},{"a":"p/matthew-fust","b":"p/quehuong-kathy-dong-pharm-d","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":"2025-10-29","type":"worked_with","via":"c/electra-therapeutics-com"},{"a":"p/matthew-fust","b":"p/thomas-geninatti-ph-d","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":null,"type":"board","via":"c/electra-therapeutics-com"},{"a":"p/matthew-fust","b":"p/thomas-geninatti-ph-d","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":"2025-10-29","type":"worked_with","via":"c/electra-therapeutics-com"},{"a":"p/nancy-stagliano-ph-d","b":"p/quehuong-kathy-dong-pharm-d","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":null,"type":"board","via":"c/electra-therapeutics-com"},{"a":"p/nancy-stagliano-ph-d","b":"p/quehuong-kathy-dong-pharm-d","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":"2025-10-29","type":"worked_with","via":"c/electra-therapeutics-com"},{"a":"p/nancy-stagliano-ph-d","b":"p/thomas-geninatti-ph-d","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":null,"type":"board","via":"c/electra-therapeutics-com"},{"a":"p/nancy-stagliano-ph-d","b":"p/thomas-geninatti-ph-d","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":"2025-10-29","type":"worked_with","via":"c/electra-therapeutics-com"},{"a":"p/quehuong-kathy-dong-pharm-d","b":"p/thomas-geninatti-ph-d","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":null,"type":"board","via":"c/electra-therapeutics-com"},{"a":"p/quehuong-kathy-dong-pharm-d","b":"p/thomas-geninatti-ph-d","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"since":"2025-10-29","type":"worked_with","via":"c/electra-therapeutics-com"}],"currency":"USD","date":"2025-10-15","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-25","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"},"name":"Beth Seidenberg, M.D.","role":"director","roleAsStated":"Director","slug":"beth-seidenberg-m-d"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-25","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"},"name":"Carl Gordon, Ph.D.","role":"director","roleAsStated":"Director","slug":"carl-gordon-ph-d"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-25","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"},"name":"Matthew Fust","role":"director","roleAsStated":"Director","slug":"matthew-fust"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-25","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"},"name":"Nancy Stagliano, Ph.D.","role":"director","roleAsStated":"Director","slug":"nancy-stagliano-ph-d"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-25","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"},"name":"Quehuong (Kathy) Dong, Pharm.D.","role":"director","roleAsStated":"Director","slug":"quehuong-kathy-dong-pharm-d"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-25","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"},"name":"Quehuong (Kathy) Dong, Pharm.D.","role":"executive","roleAsStated":"Executive Officer","slug":"quehuong-kathy-dong-pharm-d"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-25","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"},"name":"Thomas Geninatti, Ph.D.","role":"director","roleAsStated":"Director","slug":"thomas-geninatti-ph-d"}],"slug":"electra-therapeutics-com-2025-10-15-round","source":{"fact":"round","publisher":"SEC EDGAR","retrievedAt":"2026-09-25","status":"sourced","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"},"status":"sourced","type":null,"url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"}],"slug":"electra-therapeutics-com","sources":[{"fact":"round","publisher":"SEC EDGAR","retrievedAt":"2026-09-25","status":"sourced","url":"https://www.sec.gov/Archives/edgar/data/2088082/000123191925000372/primary_doc.xml"},{"fact":"existence","publisher":"electra-therapeutics.com","retrievedAt":"2026-05-20","status":"self-reported","url":"https://electra-therapeutics.com"},{"fact":"description","publisher":"electra-therapeutics.com","retrievedAt":"2026-05-20","status":"self-reported","url":"https://electra-therapeutics.com"}],"stage":null,"stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["Cloudflare","reCAPTCHA","Google Tag Manager","jQuery Migrate 3.4.1","Elementor 4.0.7","Cloudflare Bot Management","CookieYes 3.4.0","WordPress","WP Engine","Python","PHP","MySQL"],"totalRaisedUsd":134188389,"traction":[],"updatedAt":"2026-05-20","valuations":[]}